Hexobendine: Difference between revisions
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
No edit summary |
||
| Line 25: | Line 25: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Hexobendine''' is a [[vasodilator]] that acts as an adenosine reuptake inhibitor.<ref>{{cite journal |author=Kolassa N, Pfleger K |title=Adenosine uptake by erythrocytes of man, rat and guinea-pig and its inhibition by hexobendine and dipyridamole|journal= [[Biochemical Pharmacology]] |year = 1975 |volume = 24 |pages = 154–156 |url=http://ukpmc.ac.uk/abstract/MED/1168469 |doi=10.1016/0006-2952(75)90331-7}}</ref> | |||
==References== | |||
{{reflist|2}} | |||
{{Vasodilators used in cardiac diseases}} | {{Vasodilators used in cardiac diseases}} | ||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Drug]] | |||
[[Category:Vasodilators]] | [[Category:Vasodilators]] | ||
Revision as of 21:22, 24 July 2014
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C30H44N2O10 |
| Molar mass | 592.68 g/mol |
|
WikiDoc Resources for Hexobendine |
|
Articles |
|---|
|
Most recent articles on Hexobendine Most cited articles on Hexobendine |
|
Media |
|
Powerpoint slides on Hexobendine |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Hexobendine at Clinical Trials.gov Clinical Trials on Hexobendine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Hexobendine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Hexobendine Discussion groups on Hexobendine Patient Handouts on Hexobendine Directions to Hospitals Treating Hexobendine Risk calculators and risk factors for Hexobendine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Hexobendine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hexobendine is a vasodilator that acts as an adenosine reuptake inhibitor.[1]
References
- ↑ Kolassa N, Pfleger K (1975). "Adenosine uptake by erythrocytes of man, rat and guinea-pig and its inhibition by hexobendine and dipyridamole". Biochemical Pharmacology. 24: 154–156. doi:10.1016/0006-2952(75)90331-7.
- Pages with script errors
- Pages using duplicate arguments in template calls
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Cardiovascular Drugs
- Drug
- Vasodilators